Changes between Version 77 and Version 78 of NTTData

Timestamp:

Jan 6, 2022, 1:23:03 PM (4 years ago)

Author:

Elaine Meng

Comment:

--

NTTData

@@ -475 +475 @@
 
 == 1/6/2021 ==
+
+Phil, Philip, Darrell; Elaine, Eric, TomG, Greg, Zach
+
+For subsequent funding, Darrell wants to put us back on his contract, which turns over at the end of February.  Doesn't know who will be awarded the contract.  Darrell: no-cost extension of NTT contract is a possibility if we need to do a bridge. Scooter will e-mail Darrell to continue discussion.
+
+TomG asked whether the pandemic affected Darrell's research direction.  Darrell: not so much, although other NIAID groups were heavily involved in clinical data management and vaccine clinical trials. 
+
+Potential areas for next contract:
+ - Drivers of interest in cryoEM are that it is increasingly important in structural biology in general, and NIAID has a core facility with a new and enthusiastic director, James Cherry. 
+ - VR? Still very much of interest. Somewhat of a pause recently due to equipment requirements if used remotely, and pandemic-related decrease in users of their own VR facility.
+ - somewhat of a falling-out with disorganized and demanding !HubMap team. Visualizing/fetching !HubMap data is still of interest, but they may not be directly engaged.
+- medical imaging, how much emphasis should we place on ChimeraX development in this area?  Darrell: mainly interested in the context of VR, shared VR meetings.  Phil: there may be fertile ground for ChimeraX development is segmentation in 3D in VR. 2D tools not so great for segmentation.  Could also apply to 3D light microscopy, EM tomography, ...